Today

Agents

Chat

Arena

Discover

More

App

Vanda Pharmaceuticals Q2 EPS USD -1.04 - VNDA News | Rallies

Vanda Pharmaceuticals Q2 EPS USD -1.04

VNDA•2026-08-05

Vanda Pharmaceuticals reports second-quarter results

Aug. 5 (Reuters) - Vanda Pharmaceuticals Q2 net income USD -62.513 million.

Q2 basic EPS USD -1.04
Q2 operating expenses USD 114.338 million
Q2 operating income USD -63.809 million

Related News

Star Group Q3 net loss widens due to unfavorable derivative changes and higher expenses

SGU•2026-08-05

JBS NV amends syndicated revolving credit facility to US$2.65 billion, extends maturity to 2031

JBS•2026-08-05

Fidelity National Q2 revenue beats estimates on title segment growth

FNF

•

2026-08-05

Ooma to report Q2 results after market close, host investor call

OOMA•2026-08-05

CrossAmerica Q2 FY26 net income falls 17.4% to $20.8 million; revenue rises to $1.18 billion

CAPL•2026-08-05